South African Medical Device Company Alora Medical Wins International Respiratory Healthcare Award

CENTURION, South Africa - May 25, 2026 - PRLog -- Alora Medical (Pty) Ltd, a SAHPRA-licensed South African company specialising in respiratory health, received international recognition at the 2026 Global Health & Pharma (GHP) Healthcare & Pharmaceutical Awards. Its flagship RespiPEP® device range won the Best Lung Clearing Device Brand 2026 award. The GHP Awards are highly competitive and attract healthcare innovators worldwide, making this recognition distinguished.

The award underscores Alora Medical's role in accessible, non-invasive respiratory care and lung rehabilitation, supporting healthcare professionals and patients. Each year, GHP Magazine's Healthcare & Pharmaceutical Awards honour excellence in corporate performance, healthcare innovation, and global industry contribution.

This milestone highlights Alora Medical's growing presence in non-invasive respiratory care. RespiPEP® Therafizz and RespiPEP® Theravance are Positive Expiratory Pressure (PEP) devices designed for use within respiratory rehabilitation and airway clearance programmes.

The complete digital supplement and list of recognised organisations are available via the official GHP Healthcare & Pharmaceutical Awards 2026 portal (https://ghpnews.digital/issues/healthcare-and-pharmaceuti...). (see page 22).

Positive Expiratory Pressure (PEP) therapy is commonly used within respiratory care protocols to support airway clearance, lung expansion, and pulmonary rehabilitation. PEP therapy may assist with:

• Improving lung volume: Enhancing breathing capacity.
• Reducing lung hyperinflation: Supporting easier breathing in individuals with chronic respiratory conditions.
• Removing respiratory secretions: Assisting mucus clearance and pulmonary hygiene.

"We are honoured to receive this recognition from GHP Magazine," said Daminda Senekal-Griessel, spokesperson for Alora Medical. "At Alora Medical, we develop safe, reliable, affordable, standardised respiratory solutions supporting healthcare professionals and patients. This award highlights our drive to make respiratory products more accessible while upholding high industry standards.

Demand for respiratory rehabilitation and non-invasive therapy is rising globally. This is due to greater awareness of lung health, post-operative recovery, chronic conditions, and athletic performance. The growing global focus on respiratory rehabilitation, chronic lung disease management, and preventive healthcare is driving demand for innovative non-invasive respiratory therapy solutions worldwide.

Statutory & Regulatory Information

The RespiPEP® lineup features two specialised PEP therapy devices. Use only as directed under a qualified healthcare provider's supervision.

Medical professionals and procurement officers interested in learning more or requesting product information are encouraged to visit the official Alora Medical website (https://www.aloramed.co.za/). Contact us today for technical data, instructions for use, clinical specifications, or to discuss partnership opportunities. (https://www.aloramed.co.za/)

About Alora Medical (Pty) Ltd

Alora Medical (Pty) Ltd is a SAHPRA-registered and licensed South African medical device manufacturer and distributor. The company specialises in non-invasive respiratory health solutions.

Corporate & Media Contact:

• Company Name: Alora Medical (Pty) Ltd
• Registered Address: Pretoria, Gauteng, South Africa
• Department: Corporate Compliance, Investors & Sales
• Telephone: +27 68 622 7803
• Email: info@aloramed.co.za
• Website: www.aloramed.co.za